ClinicalTrials.gg
Sign In

Sexual Dysfunctions, Psychological clinical trials

The registry lists 138 studies for Sexual Dysfunctions, Psychological across more than 10 countries. 10 are recruiting or about to start. 92 of them are mainly about Sexual Dysfunctions, Psychological (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 6 narrower conditions too, such as Erectile Dysfunction: 1,184 studies, 234 open.

Get an email when these change. Save the Sexual Dysfunctions, Psychological studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
100
Terminated
10
Status unknown
9
Active, not recruiting
6
Not yet recruiting
5
Recruiting
5

Phase

Phase 3
42
Phase 2
22
Phase 1
6
Phase 4
5
Early Phase 1
1

Where

United States
62
Canada
28
United Kingdom
8
Turkey
8
Italy
7
Australia
6

Who runs them

Sprout Pharmaceuticals, Inc (13) · Warner Chilcott (7) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · BioSante Pharmaceuticals (4) · Palatin Technologies, Inc (4) · University of British Columbia (4) · Alza Corporation, DE, USA (3) · Ivix LLX (3)

What is being tested here

Drugs under test in Sexual Dysfunctions, Psychological studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Testosterone11217
Testosterone undecanoate101
BZ-371A101
NOS Enhancer BZ371A101
Flibanserin01013
Bremelanotide036
Dapoxetine066
Sildenafil003
Dehydroepiandrosterone023
BP101013

Drug classes tested here Androgens 1 open · PDE5 inhibitors 4

Coming up

0phase 3 studies under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 5 Sexual Dysfunctions, Psychological studies recruiting now, 2 (40%) set no upper age limit and 1 (20%) stop at 75 or younger. 0 (0%) take children under 18. 2 (40%) are for women only and 2 (40%) for men only; 2 (40%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
100 (0%)0 (0%)
182 (40%)2 (40%)
303 (60%)2 (40%)
403 (60%)2 (40%)
503 (60%)3 (60%)
652 (40%)3 (60%)
752 (40%)3 (60%)
852 (40%)2 (40%)

Across all 138 studies, recruiting or not: 51% stop at 75 or younger and 36% at 65; 5% take children; 72% are for women only and 11% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Sexual Dysfunctions, Psychological studies take

Of 30 interventional studies with no phase under Sexual Dysfunctions, Psychological, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase21 mo6–24 · 30 studies—21 mo6–24 · 30 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 138. Browse all 138 → or search them.